Tissue distribution and abuse potential of prucalopride: findings from non-clinical and clinical studies

BACKGROUND: Prucalopride is a selective serotonin type 4 (5-HT(4)) receptor agonist indicated for treatment of chronic idiopathic constipation (CIC) in adults (2 mg orally, daily). 5-HT(4) receptors are present in the central nervous system; therefore, non-clinical and clinical assessments were perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Derakhchan, Katayoun, Lou, Zhen, Wang, Hong, Baughman, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983627/
https://www.ncbi.nlm.nih.gov/pubmed/36876155
http://dx.doi.org/10.7573/dic.2022-6-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983627/
https://www.ncbi.nlm.nih.gov/pubmed/36876155
http://dx.doi.org/10.7573/dic.2022-6-1

Ejemplares similares